Epigenetic regulation in cardiovascular disease: mechanisms and advances in clinical trials

Y Shi, H Zhang, S Huang, L Yin, F Wang… - … and Targeted Therapy, 2022 - nature.com
Epigenetics is closely related to cardiovascular diseases. Genome-wide linkage and
association analyses and candidate gene approaches illustrate the multigenic complexity of …

Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications

Q Zhong, X Xiao, Y Qiu, Z Xu, C Chen, B Chong… - MedComm, 2023 - Wiley Online Library
Protein posttranslational modifications (PTMs) refer to the breaking or generation of covalent
bonds on the backbones or amino acid side chains of proteins and expand the diversity of …

Pathology and pathobiology of pulmonary hypertension: current insights and future directions

C Guignabert, J Aman, S Bonnet… - European …, 2024 - publications.ersnet.org
In recent years, major advances have been made in the understanding of the cellular and
molecular mechanisms driving pulmonary vascular remodelling in various forms of …

Current and future treatments of pulmonary arterial hypertension

N Sommer, HA Ghofrani, O Pak… - British journal of …, 2021 - Wiley Online Library
Therapeutic options for pulmonary arterial hypertension (PAH) have increased over the last
decades. The advent of pharmacological therapies targeting the prostacyclin, endothelin …

Sirtuin 3 deficiency exacerbates diabetic cardiomyopathy via necroptosis enhancement and NLRP3 activation

S Song, Y Ding, G Dai, Y Zhang, M Xu, J Shen… - Acta Pharmacologica …, 2021 - nature.com
Abstract Sirtuin 3 (SIRT3) is a potential therapeutic target for cardiovascular, metabolic, and
other aging-related diseases. In this study, we investigated the role of SIRT3 in diabetic …

Targeting histone deacetylases in idiopathic pulmonary fibrosis: a future therapeutic option

M Korfei, P Mahavadi, A Guenther - Cells, 2022 - mdpi.com
Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal lung disease with limited
therapeutic options, and there is a huge unmet need for new therapies. A growing body of …

[HTML][HTML] HDAC3 deficiency protects against acute lung injury by maintaining epithelial barrier integrity through preserving mitochondrial quality control

N Li, B Liu, R Xiong, G Li, B Wang, Q Geng - Redox Biology, 2023 - Elsevier
Sepsis is one common cause of acute lung injury (ALI) and acute respiratory distress
syndrome (ARDS), which is closely associated with high mortality in intensive care units …

Mechanisms of pulmonary vascular dysfunction in pulmonary hypertension and implications for novel therapies

H Christou, RA Khalil - American Journal of Physiology …, 2022 - journals.physiology.org
Pulmonary hypertension (PH) is a serious disease characterized by various degrees of
pulmonary vasoconstriction and progressive fibroproliferative remodeling and inflammation …

Mechanosensing dysregulation in the fibroblast: a hallmark of the aging heart

A Angelini, JA Trial, J Ortiz-Urbina, KA Cieslik - Ageing research reviews, 2020 - Elsevier
The myofibroblast is a specialized fibroblast that expresses α-smooth muscle actin (α-SMA)
and participates in wound contraction and fibrosis. The fibroblast to myofibroblast transition …

The short-chain fatty acid butyrate attenuates pulmonary vascular remodeling and inflammation in hypoxia-induced pulmonary hypertension

V Karoor, D Strassheim, T Sullivan, A Verin… - International journal of …, 2021 - mdpi.com
Pulmonary hypertension (PH) is a progressive cardiovascular disorder in which local
vascular inflammation leads to increased pulmonary vascular remodeling and ultimately to …